Table 4 Three months outcome among thrombolyzed AIS patients in relation to baseline characteristics
From: Short-term outcome in ischemic stroke patients after thrombolytic therapy
Favorable, N = 26, n (%) | Unfavorable, N = 11, n (%) | Death, N = 3, n (%) | Test | P value | |
|---|---|---|---|---|---|
Risk factors | |||||
Male sex, n = 22 | 15 (68.2) | 5 (22.7) | 2 (9.1) | X2 = 0.646 | 0.724 NS |
Diabetes mellitus, n = 13 | 7 (53.8) | 5 (38.5) | 1 (7.7) | X2 = 1.21 | 0.524 NS |
Hypertension, n = 25 | 17 (68.0) | 6 (24.0) | 2 (8.0) | X2 = 0.411 | 0.81 NS |
Atrial fibrillation, n = 7 | 6 (85.7) | 1 (14.3) | 0 (0.0) | X2 = 4.57 | 0.102 NS |
Hyperlipidemia, n = 14 | 9 (64.3) | 3 (21.4) | 2 (14.3) | X2 = 1.61 | 0.45 NS |
Cigarette smoking, n = 11 | 7 (63.6) | 4 (36.4) | 0 (0.0) | X2 = 1.58 | 0.46 NS |
Previous stroke/TIA, n = 7 | 5 (71.4) | 0 (0.0) | 2 (28.6) | X2 = 7.41 | 0.03 S |
Age (mean ± SD) | 62.1 ± 12.2 | 66.8 ± 11.1 | 68 ± 10.8 | F = 0.821 | 0.45 NS |
Baseline NIHSS (mean ± SD) | 10.35 ± 4.81 | 13.96 ± 3.51 | 15.24 ± 4.82 | KW = 2.51 | 0.04 S |
Admission RBS (mean ± SD) | 145.3 ± 75.1 | 177.3 ± 61.7 | 182.2 ± 67.1 | F = 1.17 | 0.56 NS |
SBP (mean ± SD) | 144.2 ± 14.2 | 155.5 ± 23.4 | 136.7 ± 25.2 | F = 2.1 | 0.143 NS |
DBP (mean ± SD) | 83.3 ± 11.5 | 89.2 ± 12.3 | 98.2 ± 14.7 | F = 2.45 | 0.1 NS |
Body mass index (mean ± SD) | 27.2 ± 3.4 | 30.2 ± 3.5 | 29.7 ± 5.9 | F = 3.24 | 0.04 S |
TOAST classification | |||||
Large vessel, n = 16 | 10 (62.5) | 5 (31.3) | 1 (6.2) | X2 = 0.218 | 0.9 NS |
Cardio-embolic, n = 7 | 5 (71.4) | 2 (28.6) | 0 (0.0) | X2 = 1.24 | 0.46 NS |
Small vessel, n = 12 | 9 (75) | 2 (16.7) | 1 (8.3) | X2 = 1.01 | 0.6 NS |
Others, n = 5 | 1 (20) | 3 (60) | 1 (20) | X2 = 5.17 | 0.08 NS |
CT findings | |||||
Size, n (%) | |||||
Large, n = 6 | 2 (33.3) | 3 (50) | 1 (16.7) | X2 = 3.91 | 0.418 NS |
Medium, n = 21 | 14 (66.7) | 6 (28.6) | 1 (4.8) | ||
Lacunar, n = 13 | 10 (76.9) | 2 (15.4) | 1 (7.7) | ||
HMCAS, n = 9 | 5 (55.6) | 3 (33.3) | 1 (11.1) | X2 = 0.505 | 0.78 |